PCSK9 and familial hypercholesterolemia: Correlations Between PCSK9 and Individual Variables in Combined Groups of Patients With Homozygous Familial Hypercholesterolemia, Heterozygous Familial Hypercholesterolemia and Control Subjects Before High‐Dose Statin Therapy and Without Control Subjects After High‐Dose Statin Therapy